VOYA - ING US, Inc. – Shares in ING Group’s U.S. retirement, investment and insurance business are up as much as 8.0% today to $26.98, the highest level since the company’s May 2nd IPO. ING US was rated new ‘buy’ at BTIG LLC with a 12-month target share price of $31.00 today. The stock has rallied nearly 40% over the IPO price of $19.50, and some options traders are positioning for the price of the underlying to extend gains during the second half of the year. November expiry options are the most active contracts by volume on VOYA today, with notable fresh interest in the Nov $25 and $30 calls. Traders appear to have purchased around 200 lots at each striking price for average premiums of $2.71 and $1.14 each, respectively. Call buyers stand ready to profit at November expiration should shares in ING US rally another 2.7% and 15% to surpass average breakeven prices of $27.71 and $31.14, respectively. Meanwhile, traders snapping up Nov $20 and $25 strike puts are positioned to make money in the event of a pullback in the price of the underlying through November expiration. The company is scheduled to report first-quarter earnings ahead of the open on Thursday. Overall options volume on VOYA is sizable, with more than 1,500 contracts in play as of 12:15 p.m. ET versus overall open interest on the stock of 190 contracts.
GRPN - Groupon, Inc. – A large trade in Groupon options in the early going on Monday looks for the price of the underlying to remain in the single-digits through January of 2014. Shares in GRPN are down 0.45% on the day at $6.94 as of 12:20 p.m. ET. The stock has increased roughly 30% since the company reported better-than-expected first-quarter revenue and a narrower-than-expected first-quarter loss on May 8th. It looks like one strategist betting shares in Groupon will trade below $10.00 through the start of 2014 sold around 50,000 calls at the Jan 2014 $10 strike for…
GRPN - Groupon, Inc. – Shares in Groupon are up 11.11% at $11.00 today on expectations the company may report better-than-expected first-quarter earnings after the final bell. Options on the stock are quite active as well, but not all of the positioning is looking for a positive earnings surprise tonight. Fresh interest building in the June expiry puts portends potential fresh record lows for the shares in the near future. One-by-two June $7.0/$9.0 ratio put spreads purchased this morning position traders to profit from limited bearish movement in the price of the underlying during the next five weeks. Of the more than 3,300 put options in play at the June $7.0 and $9.0 strikes, the largest blocks of options changing hands are the purchase of 486 $9.0 strike puts spread against the sale of 972 $7.0 strike options, done at a net premium outlay of $0.33 per contract. The ratio spread may be a profitable strategy should Groupon’s shares drop 21.1% to slip beneath the effective breakeven point at $8.67. Maximum possible profits of $1.67 per contract are available on the positions if shares in the name drop 36.4% to settle at $7.00 at June expiration. Groupon’s shares on Friday traded down to an all-time low of $9.63.
DLTR - Dollar Tree Stores, Inc. – Bearish options are in play on Dollar Tree, Inc. this morning ahead of the discount consumer goods retailer’s first-quarter earnings report on Thursday. Shares in Dollar Tree are currently down 1.5% at $101.05 as of 12:50 in New York. It looks like the investor buying a sizable debit put spread on DLTR this morning paid an average net premium of $3.31 per contract for a roughly 3,000-lot June $85/$100 spread. The position makes money if shares in…
I entered a few tournaments in Atlantic City, made it to a couple of final tables but didn't win any. It did remind me that a bluff can only get you so far – at a certain point, you have to actually have the cards in order to win. As I pointed out to Members this morning – the Global Markets have bluffed their way through the first quarter and now comes earnings season and it's time for the economy to show it's cards and now we'll see who ends up with all the chips!
These are NOT cards you want to be playing with unless you are forced. That's the thing, GS, JPM, MS, Fund Managers, etc – they HAVE to play. Since they have to play whatever cards that are dealt – they do the logical thing – THEY BLUFF! Although what's scary about the Banksters is that, when they bluff, it's like the dealer bluffing because they control so much of the game and their only real goal is to get you to play so they can rake…
GRPN - Groupon, Inc. – The provider of a diverse mix of local daily deals featuring anything from Botox injections and manicures to fine-dining experiences and cupcakes, popped up on our scanners this morning after a sizable options combo play was initiated in the May expiry. Shares in Groupon are in negative territory this afternoon, but earlier increased as much as 2.6% to touch an intraday high of $18.76. The stock, which reached a peak of $27.78 in its first day as a publicly traded company back in November, just about halved in value in the weeks following the IPO. Quick rallies in the share price paired with subsequent pullbacks have been a fairly consistent pattern for GRPN shares in 2012, though recently the stock price has been less volatile, trading in the range of roughly $16.25 to $18.60 in the past few weeks. Perhaps the relative stagnation in the shares spurred one option strategist to position for the stock to take another stab at the upside in the next couple of months. The trader appears to have sold 5,000 May $13 strike put options in order to partially finance the purchase of a 5,000-lot May $19/$22 call spread, all for a net premium outlay of $0.55 per contract. The three-way spread prepares the trader to make money should GRPN’s shares rally 7.8% over the current price of $18.14 to surpass the average breakeven point at $19.55 by expiration in May. Maximum possible profits of $2.45 per contract are available on the position as long as shares in the daily deals provider jump 21.3% to settle above $22.00 at expiration. Groupon, Inc. is scheduled to report first-quarter earnings after the market closes on May 8th.
Our senior index finished the day at 1,358.04, just 0.96 under our 10% line at 1,359. Oddly enough, it never actually crossed the line that we had predicted would be the top of this run in April of 2009. It's a simple 2% overshoot of the 100% run from the S&P bottom at 666.
If the S&P can get over the line and hold it – we will be THRILLED to finally redraw our Big Chart but, if not, then this is just the blow-off top of the range, reeling in the suckers ahead of the big reversal that no one could have possibly seen coming (except this guy but he's like 100 and just got divorced, so he's bound to be in a bad mood).
Is there anyone who was born SINCE radio who is willing to still be bearish? As you can see from David Fry's chart, since December 19th, other than a few red days out of over 40 – it's been tough to be a bear. This is what it was like in 1999, when the experienced market players would be well-hedged and missing the rally while some kid who works for him quits because he bet his student loan money on Yahoo and now drives a Porsche.
Sure 9 months later the Porsche was repossessed and the kid was flipping burgers but WE WANT TO BE THAT KID – IT'S FUN TO BE THAT KID – until it isn't again. The funny thing is, we only gave those dot com companies Millions when they IPO'd – now we give out Billions because, of course, this time is different, it's a new paradigm, this changes everything, you have to understand the new metrics, sock puppets rule….
McDonald's was founded in 1940 by two brothers actually named McDonald. Ray Krok bought the chain from them and created the World's greatest franchise which now has over 26,000 franchise operations and over 6,000 company stores employing about 1.7M people worldwide selling $24Bn worth of food a year with a $5Bn net profit. Facebook has 3,200 people but they generate $1.2M in revenues per employee ($3.8Bn) and drops $1Bn to the bottom line. Facebook's assets are mainly IP and those are about as valuable as MySpace's assets now…
This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible. Feel free to contact me directly at firstname.lastname@example.org with any questions.
Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts. After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.) Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.
Reports are coming in that, following Russian ministry urging this morning that the humanitarian mission start as soon as possible (following ongoing Ukrainian attacks on Donetsk and Eastern Ukraine), that the white humanitarian trucks of the Russian convoy are crossing the border into Ukraine customs.
As RT reports,
The first 16 trucks with Russian humanitarian aid to the residents of the Donetsk and Lugansk Regions of Ukraine are going through customs inspections at the Donetsk checkpoint on the Russia-Ukraine border.
The convoy is expected to move out to its destination in Ukraine during the night, at arou...
As Q2 2014 earnings season ends with 95% reported earnings, here is the latest update of my ongoing "thought experiment" for forecasting the S&P 500 price based on earnings fundamentals.
The chart below is based on the latest trailing twelve-month earnings (TTM) data published on the Standard & Poor's website as of August 17th, 2014. The numbers are from the spreadsheet maintained by senior analyst Howard Silverblatt. See dshort's monthly valuation update for instructions on downloading the spreadsheet.
I am compelled to digress today from our standard navigation of the economic landscape to touch upon the troubling situation playing out in Ferguson, MO.
I hope those who read this commentary and my blog would come away thinking the only side I come down upon in any situation is that of the truth. Over and above that pursuit, I hope people would also believe I have a real contempt for corruption and a real love for my fellow man.
The troubles in Ferguson are clearly very fluid and a cauldron for those who feel disenfranchised. Similarly, there are some folks who would use the loss of a young man’s life to further incite violence for violence sake.
Might America be able to use the unrest in Ferguson to have an intelligent conversation on the issues involved? I certainly hope so.
As much as many people might like to point at one reason or anoth...
It’s an ugly day for investors in Elizabeth Arden, with shares in the name losing roughly one-quarter of its value overnight after the retailer of beauty products and fragrances reported a wider than expected loss and sales that were lower than analysts anticipated. Shares in the name are down more than 23% in the final hour of trading to stand at $14.95.
On Friday of last week we wrote a short note about put option activity on the stock...
As many investors enjoy the final weeks of summer, some optimistic bulls seem to be positioning themselves well ahead of Labor Day in anticipation of a fall rally. Indeed, last week’s action was impressive. After only a mere 4% correction, investors continued to brush off the disturbing violence both at home and abroad, and they took the minor pullback as their next buying opportunity. But was that really all the pullback we’re going to get this year? I doubt it. But I also believe that nothing short of a major Black Swan event can send this market into a deep correction.
In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, review our weekly fundamentals-based SectorCast rankings of the ten U.S. business sectors, and then ...
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
Author Helen Davis Chaitman is a nationally recognized litigator with a diverse trial practice in the areas of lender liability, bankruptcy, bank fraud, RICO, professional malpractice, trusts and estates, and white collar defense. In 1995, Ms. Chaitman was named one of the nation's top ten litigators by the National Law Journal for a jury verdict she obtained in an accountants' malpractice case. Ms. Chaitman is the author of The Law of Lender Liability (Warren, Gorham & Lamont 1990)... Since early 2009, Ms. Chaitman has been an outspoken advocate for investors in Bernard L. Madoff Investment Securities LLC (more here).
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Well PSW Subscribers....I am still here, barely. From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.
First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices. Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment. Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer. For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...
I just wanted to be sure you saw this. There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.
If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.
Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.
Note: The material presented in this commentary is provided for
informational purposes only and is based upon information that is
considered to be reliable. However, neither MaddJack Enterprises, LLC
d/b/a PhilStockWorld (PSW) nor its affiliates
warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.